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ABSTRACT: Growing antimicrobial resistance (AMR) is a serious global
threat to human health. Current methods to detect resistance include
phenotypic antibiotic sensitivity testing (AST), which measures bacterial
growth and is therefore hampered by a slow time to obtain results (∼12−
24 h). Therefore, new rapid phenotypic methods for AST are urgently
needed. Nanomechanical cantilever sensors have recently shown promise
for rapid AST but challenges of bacterial immobilization can lead to
variable results. Herein, a novel cantilever-based method is described for
detecting phenotypic antibiotic resistance within ∼45 min, capable of
detecting single bacteria. This method does not require complex, variable
bacterial immobilization and instead uses a laser and detector system to
detect single bacterial cells in media as they pass through the laser focus.
This provides a simple readout of bacterial antibiotic resistance by
detecting growth (resistant) or death (sensitive), much faster than the
current methods. The potential of this technique is demonstrated by determining the resistance in both laboratory and clinical
strains of Escherichia coli (E. coli), a key species responsible for clinically burdensome urinary tract infections. This work provides the
basis for a simple and fast diagnostic tool to detect antibiotic resistance in bacteria, reducing the health and economic burdens of
AMR.
KEYWORDS: diagnostics, antimicrobial resistance, cantilevers, bacteria, antibiotics, optical
■ INTRODUCTION
Antimicrobial resistance (AMR) is steadily increasing and
poses a major threat to global health, with estimates of AMR
leading to 10 million deaths per year and costing the global
economy $100tn by 2050.1,2 The increase in AMR has been
caused by several factors including the overuse of antibiotics.3
Despite the growth of AMR, methods for antibiotic
susceptibility testing (AST) have remained relatively un-
changed for several decades.
In common AST methods, bacterial growth is used as a
measure of sensitivity to antibiotics, determined directly by an
increase in media turbidity (the number of bacteria) or
indirectly by the release of fluorescent metabolites. These
phenotypic methods provide in vitro confirmation of
resistances in isolated bacterial species, which are inferred
from known resistance genes in genetic methods. However,
phenotypic methods are inherently limited by the speed of
bacterial growth (e.g., the doubling time of Escherichia coli (E.
coli) is 20 min, whereas Mycobacterium tuberculosis (M.
tuberculosis) is 12−15 h), meaning these methods require
long culture times (12−24 h, or longer for some species) for an
observable change to occur. These delays result in empirical
prescribing of antibiotics for patients instead of targeted
treatment, which has been shown to increase mortality from
sepsis fivefold,4 in addition to being a driver of resistance.
Having access to the identity and antibiogram of the pathogen
just a few hours earlier could avoid unnecessary costs
associated with inappropriate prescribing, increase patient
welfare, and reduce the effects of AMR.5,6 Therefore, to reduce
the damaging effects of AMR, we require solutions in the form
of novel diagnostic tools to detect resistance and improve
antibiotic stewardship, surveillance, and patient manage-
ment.7,8
Recent developments in this field have exploited single-cell
methods for faster and more sensitive detection of antibiotic
resistance. This has been achieved by miniaturizing the volume
observed using microfluidics,9−12 measuring mass or mechan-
ical changes,11,13,14 or by exploiting machine learning
techniques for video tracking analysis of single cells.15−17
Despite advances in the detection limit and speed of testing,
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these are mostly complex setups, which remain far from point
of care.
Recently, a nanomechanical method for detecting the
viability of bacterial cells immobilized on soft cantilevers was
reported by Longo et al.,18−21 which has attracted much
attention by virtue of its ability to detect AST within minutes.
Here, we exploit an optical signal as an alternative method to
the nanomechanical method reported by Longo et al., with the
advantage that it does not require complex immobilization
chemistries and optimization of bacterial seeding densities
(Figure 1). This novel optical method is able to rapidly detect
antibiotic resistance in bacterial solutions with single-cell
resolution.
■ RESULTS AND DISCUSSION
In the nanomechanical method, a nonspecific linker molecule
was used to coat the cantilever surface with hundreds of
bacterial cells, and the motion of the cantilever was monitored
using a laser before and after the application of an antibiotic.
However, there remains speculation as to the origin of the
nanomechanical signal. Herein, when we initially sought to
reproduce the Longo method and apply it to clinical samples, a
significant issue was found in obtaining consistent bacterial
immobilization on the cantilever surface. Bacterial immobiliza-
tion numbers were found to vary from cantilever to cantilever,
from zero/low numbers to very high clumpy immobilization
(Figure S1). Efforts to identify the source of variability by
testing different immobilization conditions resulted in
significant variation across conditions (from 90 to >1000
cells, Figure S2) with no clear pattern identified. For example,
out of 60 cantilevers functionalized with bacterial cells, only 28
achieved measurable bacterial immobilization of which only
five had “optimal coverage” of 500−600 cells. Additionally, no
significant difference was found between the mechanical
cantilever motion for preantibiotic and postantibiotic treat-
ments for these five cantilevers (P = 0.4569, Figure 2).
Figure 1. Principle of the rapid optical AST method. (a) Illustration of bacterial cells inoculated in growth media with antibiotic molecules, with
laser reflecting off the cantilever surface onto a photodiode detector. Bacteria in the solution move through the laser beam, which can be observed
as peaks in the photodiode signal. The photodiode signal measured from the media solution decreases after the addition of the antibiotic for
sensitive strains. (b−d) Photodiode signal (b) without bacterial inoculant, (c) with bacteria in solution, and (d) 45 min after addition of the
antibiotic.
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Figure 2. Data analysis of initial mechanical signal experiments. (a, b) Subtraction of linear regression from raw data and large peaks not caused by
mechanical motion of the cantilever identified (*). (c, d) Averaging of variance over 10 s segments and (e) removing large peaks from the average
variance calculation for one experiment. (f) Average variance for n = 5 experiments, pre-treatment (green, pre-amp) and 15 min post-treatment
(red, post-amp) with 125 μg/mL ampicillin for optimal immobilization count cantilever D experiments. P = 0.4569. Cantilever D: k = 0.06 N/m,
f res = 4 kHz.
Figure 3. Signal caused by bacteria crossing the laser path decreases after 45 min from antibiotic addition. (a) At a low bacterial inoculant
concentration, individual peaks can be identified within the signal. Combined optical tracking and signal measurement shows (a) of single
bacterium (blue circle) passing through the laser path (b, optical images) as a single peak in the signal (c). (d) Bacterial concentration (CFU, ×
105) correlates with the number of bacterial crossings.
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Figure 4. Peak identifying and counting analysis. (a) Number of bacterial crossings in 800 s was calculated and plotted over the course of the
experiment. (b) Raw data traces for points at “media only” (gray box), “inoculated media” (black box), and “inoculated media containing an
antibiotic” (green box). Peaks identified (blue triangles) as ±0.5 nm from previous peaks. Each point in (a) is the total number of peaks identified
in 800 s.
Figure 5. Systematic analysis of antibiotic susceptibility in clinical and laboratory strains of E. coli. (a) Susceptibility of BL21-WT (S, green) and
BL21-ampR E. coli (R, red) to 125 μg/mL ampicillin. Addition of bacteria (yellow dotted line) and antibiotic solution (dark blue dotted line) to the
system cause large fluctuations in the signal as the liquid is mixed, which dissipate within ∼800 s. The number of bacterial crossings in a given time
period, here 800 s, is plotted. The number of bacterial crossings shows a decrease in 45 min after antibiotic addition. (b) Determination of the
resistance profile, with sensitivity readout (rsensitivity). rsensitivity was calculated from the ratio of crossings postantibiotic and preantibiotic treatments at
set time points marked in blue in (a). Strains were determined to be sensitive (S) if rsensitivity < 1 (green) or resistant (R) if rsensitivity ⩾ 1 (red), cut off
(rsensitivity = 1) shown as a blue dashed line, shown for five concentrations of ampicillin and BL21 E. coli. (c) Susceptibility of a clinical isolate of E.
coli, determined to be resistant to both ampicillin (purple line) and trimethoprim (blue line). (d) Determination of resistance profile. rsensitivity for
repeats of clinical isolate with 125 μg/mL trimethoprim and ampicillin. Antibiotic concentrations are given in μg/mL.
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However, many large “peaks” observed in the raw data were
found to be correlated temporally and spatially with the
bacterial cells in solution passing through the laser path.
We exploited this observed optical signal as an alternative
method to the above-mentioned nanomechanical method.
This optical method uses a cantilever, a laser, and a sensitive
photodetector to measure the effect of antibiotics on bacterial
growth, as briefly described here. A reflective surface (a small
stiff cantilever) is immersed in filtered growth media (4 mL) in
a small Petri dish, off which a laser is reflected onto a
photodiode detector (Figure 1a). Stiff cantilevers (AC160 TS,
k = 26 N/m) were selected to disentangle the effect of the
optical signal from the nanomechanical motion of the
cantilever. In the bacterial growth media (LB media) before
inoculation with bacterial cells, no variation in the laser signal
was observed (Figure 1b). On inoculation with bacterial cells,
the free bacteria in the growth media were observed to move
through the path of the laser. This cell movement in solution
interferes with the laser beam, causing it to shift on the
detector, observable as peaks in the signal (Figure 1c). On
addition of an antibiotic to the media, cell death of antibiotic-
sensitive bacteria occurs, and fewer bacteria are detected
passing through the laser. This results in a decrease in the
number of peaks after ∼45 min (Figure 1d).
To determine the origin of the signal, the bacterial
concentration in solution was reduced to ∼105 CFU (colony
forming units, a standard measure of bacterial concentration).
At this concentration, individual bacterial crossing events can
be observed as peaks within the optical signal (Figure 3a).
When a single bacterium is tracked optically crossing the path
of the laser (Figure 3b, blue circle), a corresponding peak in
the signal can be observed in the data (Figure 3c). These peaks
are of varying width and amplitude, due to differing angle and
distance at which the bacteria pass through the laser. These
single bacterial cell crossing events give this system single-cell
resolution at this low bacterial concentration. However, the
limit of detection has not been measured. As bacteria replicate
and cell numbers increase in the system (i.e., increasing CFU),
the number of peaks in the signal also increases (Figure 3d),
indicating that it is the bacteria that give rise to the signal. In
addition, this suggests that bacterial growth leads to an increase
in the signal over time (further shown in Figure S3).
The number of peaks observed in the raw signal is linked to
the number of viable bacteria in solution, which can exploited
to determine the antibiotic resistance. If the number of peaks
(or bacterial crossings) is measured at distinct time points
during an experiment (e.g., “media only” (gray box),
“inoculated media” (black box), and “inoculated media
containing an antibiotic” (green box)) (Figure 4), a distinct
trend appears where bacterial crossings increase on addition of
bacteria to the system and decrease around 45 min (about two
replication cycles for E. coli) after the addition of an antibiotic
in the case of sensitive strains. The two peaks observed in the
signal correspond to the addition of bacteria and an antibiotic
(Figure 5a, yellow and dark blue dotted lines, respectively) and
occur due to mixing of the system. These peaks settle to a
baseline and are observed in control experiments (Figure S3,
points “3” and “4”). This trend is not observed in a control
where the growth media is added without an antibiotic as the
number of crossings continues to rise over time due to cell
replication (Figure S3). Here, an exponential curve is observed
over time, correlating to the expected exponential growth of
bacteria in the system.
Using this method, sensitive and resistant strains of E. coli
can be differentiated. As described above, a reduction in the
signal after addition of an antibiotic for sensitive strains is seen
(Figure 5a, green); for resistant strains, there is an increase in
signal (Figure 5a, red). Though the trend remains the same,
the magnitude of the signal change can vary (Figure S4a)
based on several factors, which effect growth rates, including
inoculant concentration, strain, and temperature, for example.
The data were therefore normalized to the baseline taken
before the addition of the antibiotic when comparing between
experiments (Sbaseline) (Figure S4b,c).
To obtain a systematic readout of antibiotic sensitivity
across experiments, including multiple strains and antibiotics, a
normalized measure of bacterial growth was determined as
follows. Antibiotic sensitivity (rsensitivity) is defined as the ratio
of Sbaseline and 45 min postantibiotic treatment (Santibiotic),
shaded blue in Figure 5a. rsensitivity provides a binary readout of
sensitivity, rsensitivity ≤ 1 indicates cell death or inhibition of
bacterial growth and sensitivity to the antibiotic in solution;
rsensitivity > 1 indicates bacterial growth and therefore resistance
to the antibiotic used. This method allows both bactericidal
and bacteriostatic antibiotics to be used as rsensitivity < 1
indicates a decrease in cell number or cell death (bactericidal);
rsensitivity = 1 would indicate inhibition of growth but little cell
death (bacteriostatic). As shown in Figure 5a, for ampicillin,
rsensitivity = 0.5 for the green strain (sensitive) and rsensitivity = 1.1
for the red strain (resistant). For kanamycin, rsensitivity = 0.92 for
a sensitive strain and rsensitivity = 2.0 for a resistant strain (green
and red, respectively, Figure S5).
Having shown that rsensitivity can be used as a measure of
bacterial sensitivity, this method was applied across a range of
concentrations of ampicillin to determine the minimum
inhibitory concentration (MIC) for the E.coli strain BL21
(Figure 5b). The MIC value is defined as the lowest
concentration of an antibiotic that will inhibit the visible
growth of a bacterial strain22 and is used to determine clinical
breakpoints and provide patient-dose information for prescrib-
ing treatment. At low ampicillin concentrations (0−12.5 μg/
mL), rsensitivity > 1, and at increased ampicillin concentrations
(50−125 μg/mL), rsensitivity < 1. This indicates an MIC of
12.5−50 μg/mL ampicillin for E.coli BL21. This result is within
the range determined by broth microdilution, the gold-
standard method (8−16 μg/mL). Despite difficulties in
measuring MICs,23,24 these values are used by clinicians
when making decisions about patient care (antibiotic selection
and dosage), and hence, are an important result for any new
diagnostic tool for accurate measurement.
Uropathogenic E. coli (UPEC) is the leading cause of urinary
tract infections (UTIs)25 and is clinically burdensome across
the globe. AMR has increased in UTIs and hence represents an
excellent clinical target for a new diagnostic tool. The potential
of this rapid optical AST method was demonstrated by testing
an E. coli clinical isolate. As shown in Figure 5c, treatment of
the clinical isolate with 125 μg/mL ampicillin and
trimethoprim resulted in no decrease in signal and gave
rsensitivity > 1 within 45 min (Figure 5d). This was confirmed by
broth microdilution (resistance > 256 μg/mL ampicillin and
trimethoprim). These detected resistances agreed with the
resistance spectrum obtained from the hospital (Great
Ormond Street Hospital, London) measured using the gold-
standard method in a clinical laboratory (Table S1). This study
demonstrates the ability of this method to successfully carry
out an AST for a strain of bacteria isolated from a patient
ACS Sensors pubs.acs.org/acssensors Article
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within 45 min of the addition of the antibiotic, faster than
traditional methods of AST measurements (24 h).
To conclude, in the face of AMR, novel rapid methods to
detect resistance in bacteria are needed to prevent their further
spread and development. This study has shown that this
optical AST method can rapidly differentiate between resistant
and sensitive phenotypes in laboratory and clinical strains of E.
coli and determine MIC values in the same range as the current
gold-standard methods. A readout of bacterial sensitivity was
obtained within ∼45 min of the addition of the antibiotic. This
method lends itself to miniaturization and automation, for
example, requiring a small stable reflective surface, which could
be immersed within a 96-well plate for automated reading, with
a laser and a photodetector readout. Further miniaturization to
a microfluidic environment would be advantageous as the
observed volume would be significantly smaller, allowing for
even faster detection time and increased sensitivity. This
method can be exploited as a new rapid phenotypic method for
AST to provide these time-critical results to determine patient
care and antibiotic stewardship.
■ EXPERIMENTAL SECTION
Experimental Method. A stiff AC160 TS cantilever (k = 26 N/
m; Olympus, Japan) was loaded onto an AFM head (JPK Nanowizard
3 ULTRA Speed; JPK Instruments, Germany) and immersed in
filtered Luria Broth (LB; Sigma-Aldrich, USA) in a 35 mm diameter
glass-bottom Petri dish (WillCo Wells, Netherlands). The cantilever
spring constant was calibrated using the thermal noise method with
JPK software to convert vertical deflection from volts to nm. The
cantilever was allowed to equilibrate for 15 min, during which time
the vertical deflection of the laser was measured. The LB media was
then inoculated with bacteria to a constant concentration (∼105
CFU) and recording was started again for another 40 min to obtain a
preantibiotic baseline. An antibiotic solution was then added directly
to the LB + bacteria solution to a desired final concentration, and
deflection recording was then measured.
During experiments, only the real-time scan function was used to
monitor the vertical deflection of the laser. Experiments were
conducted at 28 °C in an acoustic isolation hood. Prior to the start
of the experiments, the AFM laser was left on for ∼2 h to ensure the
laser had warmed up fully and to reduce laser power fluctuations,
which would affect the drift of the signal.
Reagents. Luria broth (LB) and antibiotics (ampicillin,
kanamycin, and trimethoprim) were all supplied by Sigma-Aldrich
(USA).
Bacterial Strains. E. coli BL21(DE3)pLysS competent cells
(Promega, UK) were selected for their suitability for transformation
with a plasmid containing ampicillin resistance (pRSET/EmGFP
plasmid; Invitrogen, UK).
A clinical isolate of E. coli was obtained from the microbiology
repository of the Great Ormond Street Hospital (London, UK).
Bacterial Preparation. An LB media (Sigma-Aldrich) plate was
streaked with BL21 E. coli (Promega) or clinical isolate E. coli
(obtained from the Great Ormond Street Hospital) from frozen
stocks in a sterile hood. These were grown up overnight at 37 °C. A
single colony was used to inoculate 4 mL of LB media, which was
incubated at 37 °C for 2 h (225 rpm. shaking), to obtain a mid-log
phase growth. The OD600 of the culture was measured using a
Nanodrop One C (Thermo Scientific), and the final OD600 for
bacterial inoculation for experimental measurements was adjusted to
keep as constant as possible.
Bacterial Transformation with Ampicillin Resistance. An
aliquot of a competent bacterial stock was thawed in ice for 20−30
min. A volume of 1−5 μL (10 pg−100 ng) of pRSET−EmGFP
plasmid (Invitrogen, CA, USA) was mixed with 25 μL of thawed
bacterial solution and incubated for 5−10 min in ice followed by a
heat shock treatment at 42 °C for 40 s and freezing for further two
minutes. A volume of 500 μL of warmed SOC media was added, and
this was incubated at 37 °C at 225 rpm. for 1 h. A volume of 50 μL
was plated onto an agar plate, which contained 50 μg/mL of a
nafcillin/ampicillin mixture. This plate was incubated overnight at 37
°C, and colonies used were made into frozen stocks for experimental
use.
Data Analysis. Vertical deflection data (nm) were recorded on
JPK Nanowizard 3 software at 20 kHz sampling frequency. The raw
data (Figure S6a) were then processed in 800 s “chunks” using an
analysis code written in Matlab. This code applied a Savitzky−Golay
finite impulse response (FIR) smoothing filter of polynomial order 2
to the data, with a filtering frequency of 101 Hz (Figure S6b). The
Savitzky−Golay smoothing filter was chosen as this function can filter
noisy data effectively without removing the high-frequency data.
To identify the number of bacterial crossings, both local maxima
and minima were identified, as bacteria moving through the laser were
observed to cause both peaks and dips in the signal (Figure S6c, peaks
labeled with blue triangles). A “Peak Finder” function was used to
identify the local minima/maxima in the signal, where a “peak” was
defined as having a threshold drop of at least 0.5 nm on each side.
This was to ensure that only the larger peaks were counted, which
correspond to bacteria moving across the laser. Smaller “noise” seen in
the signal was not attributed to actual bacterial crossings but could be
due to partial crossings or a change of orientation of bacteria within
the laser during a crossing. This threshold peak prominence value of
0.5 nm was applied empirically across all files when carrying out the
analysis to remove any bias of identifying peaks in the signal.
Across the experiment, the number of peaks was calculated for a
subsampled time frame to increase the resolution of the data from 800
to 267 s and plotted across the experimental conditions of LB media,
addition of bacteria, and addition of the antibiotic (Figure S6d).
To calculate the antibiotic sensitivity (rsensitivity), the ratio of the
signal preantibiotic addition, Sbaseline, and 45 min postantibiotic
addition, Santibiotic was used (Figure S6d). rsensitivity provides a binary
readout of sensitivity; rsensitivity ≤ 1 indicates cell death or inhibition of
bacterial growth and sensitivity to the antibiotic in solution; rsensitivity >
1 indicates bacterial growth and therefore resistance to the antibiotic
used.
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